The Australia & New Zealand dental biomaterials market size was valued at USD 25.1 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2020 to 2027. Rapid innovations in healthcare have augmented the need among the manufacturers of dental biomaterials to incorporate new technologies and software into their products to maintain market demand. As the manufacturers of dental biomaterials have incorporated innovations into their products, the scope for growth of companies has increased and these companies are entering into dental biomaterials space. Increasing awareness regarding dental hygiene is also one of the important factors responsible for market growth. There are around 1,50,000 registered dental hygienists in Australia. These dental hygienists help people to maintain their oral health by providing them with proper dental plan and hygiene techniques. These professionals are good at recommending appropriate oral hygiene products and thus are anticipated to increase awareness levels and adoption of these products.
There are also other factors such as the growing trend of aesthetic dental restoration among the young and adult population and FDA regulations that have to be considered. Increasing product complexity, availability of new types of biomaterials, and growing regulatory oversight are some of the factors creating the need for dental biomaterials.
The increasing prevalence of cavities is a major factor in the growth of the dental biomaterials market. As per the Global Burden of Disease Study Report 2020, approximately 2.3 billion individuals have dental caries of permanent teeth and more than 530 million children have dental caries of primary teeth. According to the WHO, consumption of tobacco and alcohol and an unhealthy diet are among the few common causes of oral diseases globally. All these oral diseases require professional dental care, which is acting as a high-impact rendering driver for the dental biomaterials market.
The metallic biomaterials segment accounted for the largest revenue share of 34.8% in 2019. The growth of this segment is attributed to the increasing prevalence of dental diseases and the rising demand for dental biomaterials in developing countries. The rapidly growing aging population, along with the increasing prevalence of dental diseases, is a key factor likely to fuel the segment growth during the forecast period.
Rising adoption of metallic biomaterial products in emerging and developed markets and increasing innovations in the development of new biomaterials for dental use are among the major factors contributing to the segment growth. Recent developments have been made in smart biomaterials as well as in the construction of hard tissue repair and regeneration. Hard tissues include dentin, tooth enamel, and cementum. As there are rising cases of dental caries worldwide, demand for hard tissue repair and regeneration procedures is also increasing.
Increasing usage of metallic biomaterials is related to the rising incidence of implant-related complications due to poor implant integration and inflammation. The use of dental implants has grown intensely over the past years, driven by the increasing aging population in developed countries and the desire to maintain quality of life by maintaining oral health. Hence, due to these reasons, the segment is expected to witness growth over the forecast period.
On basis of end use, the dental hospitals and clinics accounted for the largest revenue share of 56.4% in 2019 owing to the increasing cases of dental diseases. Dental hospitals and clinics offer various dental treatments through skilled staff and certified professionals, who help lower the risk of complications. Therefore, people prefer dental hospitals and clinics to perform all types of dental treatments. Furthermore, the availability of various biomaterials to treat oral disorders is expected to drive the segment over the forecast period. Increasing dental disorders and rising awareness regarding oral hygiene are also responsible for the growth of the segment over the forecast period.
Based on application, the implantology segment accounted for the largest revenue share of 43.1% in 2019 owing to growing dental problems and the increasing aging population with dental disorders. The rising use of dental implants worldwide is responsible for segment growth over the forecast period. Globally, there is an increasing demand for dental implant solutions and aesthetic treatments. On the other hand, the adoption of cosmetic dentistry is significantly thriving in both developing and developed countries, mainly due to changing lifestyles, rising focus on dental aesthetics, and increasing awareness about dental implants. Due to these reasons, the implantology segment is expected to exhibit lucrative growth in the forecast period.
Implantology is the part of dentistry that is dedicated to dental implants. Implantology is an artificial tooth root that is inserted into the jawbone. It is most commonly present in the form of a screw that is composed of titanium alloy or titanium. The high success rate associated with the procedure is one of the major reasons for the increasing demand for implantology in recent years. According to the National Institute of Health Report 2016, dental implants have a 97.0% success rate and is considered to be the most advanced solution for missing tooth caused by decay or trauma.
Australia dominated the market in 2019 with a share of over 65.0% and is anticipated to grow at a substantial rate over the forecast period. Increasing cases of dental carries is a major factor responsible for the growth of the market in this country. According to the Australian Department of Health, dental health in Australia improved over the last 25 to 30 years and initiatives, such as adding fluoride to drinking water, have helped reduce tooth decay in children and adults. Despite this, according to the Australian Institute of Health and Welfare, 3 out of 10 adults in the age group of 22 to 44 years have untreated tooth decay and 3 in 10 people were observed to delay or avoid dental visits because of the high cost. On average, Australian households spent USD 7.62 per week on dental fees from 2015 to 2016. In 2016, there were 57.7 dentists per 100,000 people in the country.
According to Dental Tribune in 2019, the prevalence of dental caries continues to affect adults in the country as, on average, a person had 1.4 tooth surfaces with decay. In addition, the prevalence of periodontal disease is increasing and 30% of adults experience moderate or severe periodontitis, as per a survey by the Australian Periodontists. The prevalence of peri-implant mucositis and peri-implantitis was 47% & 21%, respectively, among the Australian population.
Companies are engaging in partnerships and mergers & acquisitions, aiming to strengthen their product portfolio, increase manufacturing capacities, and provide competitive differentiation. For example, in July 2019, Straumann Holding AG had entered into a partnership with Yuhan Corporation to expand the international business of Warantec, an established and respected Korean implant brand, in which Yuhan currently holds a controlling stake.
Moreover, Datum Dental, Ltd. announced the expansion of its global network in 2018. This expansion will help Dentsply Sirona to increase its sales in new territories, such as Argentina, Belgium, Colombia, Greece, Scandinavia, Singapore, and Vietnam, with more new partnerships in the pipeline. Some prominent players in the Australia & New Zealand dental biomaterials market include:
Straumann Holding AG
Geistlich Pharma AG
Zimmer Biomet Holding, Inc.
Dentsply Sirona, Inc.
Carpenter Technology Corporation
Kuraray Co. Ltd.
Ivoclar Vivadent AG
Market size value in 2020
USD 27.1 million
Revenue forecast in 2027
USD 48.3 million
CAGR of 8.6% from 2020 to 2027
Base year for estimation
2016 - 2018
2020 - 2027
Revenue in USD million and CAGR from 2020 to 2027
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Type, application, end-use, region
Australia; New Zealand
Key companies profiled
Ivoclar Vivadent AG; Henry Schein; Medtronic; Kuraray Co. Ltd.; Royal DSM
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the country and regional levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the Australia & New Zealand dental biomaterials market report on the basis of type, application, end-use, and region:
Type Outlook (Revenue, USD Million, 2016 - 2027)
Application Outlook (Revenue, USD Million, 2016 - 2027)
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Dental Hospitals and Clinics
Dental Academies and Research Institutes
Regional Outlook (Revenue, USD Million, 2016 - 2027)
b. The ANZ dental biomaterials market size was estimated at USD 25.1 million in 2019 and is expected to reach USD 27.1 million in 2020.
b. The ANZ dental biomaterials market is expected to grow at a compound annual growth rate of 8.6% from 2020 to 2027 to reach USD 48.3 million by 2027.
b. Australia dominated the ANZ dental biomaterials market with a share of 65.9% in 2019. This is attributable to rising awareness regarding biomaterials coupled with increasing cases of dental caries.
b. Some key players operating in the ANZ dental biomaterials market include Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holding, Inc, and Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co. Ltd., Medtronic, Henry Schein, Ivoclar Vivadent AG.
b. Key factors that are driving the ANZ dental biomaterials market growth include the increasing prevalence of cavities, rising aging population with dental disorders, and growing dental tourism in emerging countries.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."